State Street Global Advisors announced today that the SPDR® S&P Biotech ETF (NYSE: XBI- News) received payment as an authorized claimant from a class action settlement related to Dendreon, Corp. The total amount payable to the Fund is listed below. When the Fund calculates its net asset value (“NAV”) per share on Tuesday, August 19, 2014, it is estimated that the Fund’s NAV will be impacted by the receipt of the payment in the amount stated below based on the shares outstanding as of August 15, 2014.
|Fund||SettlementPayment||Shares Outstandingas of August 15, 2014||Per Share Amount|
|SPDR® S&P Biotech ETF||$233,312||7,500,000||$0.0311|
* Assets under management include the assets of the SPDR® Gold ETF (approximately $33 billion as of June 30, 2014), for which State Street Global Markets, LLC, an affiliate of SSGA, serves as the distribution agent.Note to Editors: SPDR® Exchange Traded Funds SPDR ETFs are a comprehensive family spanning an array of international and domestic asset classes. SPDR ETFs provide professional investors with the flexibility to select investments that are precisely aligned to their investment strategy. Recognized as the industry pioneer, State Street—in partnership with the American Stock Exchange—created the first ETF in 1993 (SPDR S&P 500 – Ticker SPY). Since then, we’ve sustained our place as an industry innovator through the introduction of many ground-breaking products, including first-to-market successes with gold, international real estate, international fixed income and sector ETFs. SPDR ETFs are managed or marketed by SSGA or SSGA Funds Management, Inc, a registered investment adviser and wholly owned subsidiary of State Street Bank and Trust Company. Risk associated with equity investing include stock values which may fluctuate in response to the activities of individual companies and general market and economic conditions. The information provided does not constitute investment advice and it should not be relied on as such. It should not be considered a solicitation to buy or an offer to sell a security. It does not take into account any investor's particular investment objectives, strategies, tax status or investment horizon. You should consult your tax and financial advisor. All material has been obtained from sources believed to be reliable. There is no representation or warranty as to the accuracy of the information and State Street shall have no liability for decisions based on such information. Investing involves risk including the risk of loss of principal. The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without State Street's express written consent.
Non-diversified funds that focus on a relatively small number of securities tend to be more volatile than diversified funds and the market as a whole.ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns. Because of their narrow focus, sector funds tend to be more volatile than funds that diversify across many sectors and companies. The Fund invests by sampling the Index, holding a range of securities that, in the aggregate, approximates the full Index in terms of key risk factors and other characteristics. This may cause the fund to experience tracking errors relative to performance of the Index. Distributor: State Street Global Markets, LLC, member FINRA, SIPC, a wholly owned subsidiary of State Street Corporation. References to State Street may include State Street Corporation and its affiliates. Certain State Street affiliates provide services and receive fees from the SPDR ETFs. Before investing, consider the funds’ investment objectives, risks, charges and expenses. To obtain a prospectus which contains this and other information call 1-866-787-2257 or visit www.spdr.com . Read it carefully. CORP-1078 Expiration Date - 08/31/2015